Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
暂无分享,去创建一个
Yoon-La Choi | Do-Hyun Nam | H. Seol | Jung-Il Lee | D. Nam | Y. Ko | Yoon-La Choi | H. Lee | K. Joo | Kyeung Min Joo | Jung-Il Lee | Hye Won Lee | Young-Hyeh Ko | Ho Jun Seol | Hyun Jung Ju | Hyunjeong Ju
[1] K. Chin,et al. Computational BAC clone contig assembly for comprehensive genome analysis , 2004, Genes, chromosomes & cancer.
[2] W. Travis,et al. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. , 2011, Seminars in respiratory and critical care medicine.
[3] S. Koo,et al. High Frequency of Genetic Alterations in Non-small Cell Lung Cancer Detected by Multi-target Fluorescence In Situ Hybridization , 2007, Journal of Korean medical science.
[4] Kari Chansky,et al. The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] J. Inazawa,et al. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] Hanlee P. Ji,et al. Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma. , 2006, Cancer research.
[7] C. McCulloch,et al. Review Article Multiple roles of a-smooth muscle actin in mechanotransduction , 2006 .
[8] Shigemi Kinoshita,et al. Activation of the PKB/AKT pathway by ICAM-2. , 2002, Immunity.
[9] Z. Ram,et al. The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain , 2009, Clinical Cancer Research.
[10] 中城 正夫. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung , 2002 .
[11] Ajay N. Jain,et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.
[12] Manran Liu,et al. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells , 2011, Molecular and Cellular Biochemistry.
[13] G. Goodall,et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. , 2011, The Journal of clinical investigation.
[14] Yeul-Hong Kim,et al. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung. , 2007, Lung cancer.
[15] Ian G. Campbell,et al. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma , 2012, Hereditary Cancer in Clinical Practice.
[16] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[17] Ronald W. Davis,et al. Allele quantification using molecular inversion probes (MIP) , 2005, Nucleic acids research.
[18] S. Digumarthy,et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Peter,et al. Does CD95 have tumor promoting activities? , 2005, Biochimica et biophysica acta.
[20] L. Tanoue,et al. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma , 2010 .
[21] Yusuke Nakamura,et al. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. , 2006, International journal of oncology.
[22] M. Bittner,et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. , 2007, Lung cancer.
[23] D. Ball,et al. Notch in lung development and lung cancer. , 2004, Seminars in cancer biology.
[24] F. Bray,et al. Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.
[25] 努 祖母井. Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer , 2000 .
[26] V. Rusch,et al. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] M. Peter,et al. CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells , 2004, The EMBO journal.
[28] Jin Man Kim,et al. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of the lung , 2009, BMC Cancer.
[29] P. Spellman,et al. High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays , 2009, BMC Medical Genomics.
[30] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[31] Gaetano Rocco,et al. Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line , 2011, PloS one.
[32] Wei Wei,et al. Metastatic patterns in adenocarcinoma , 2006, Cancer.
[33] D. McMillin,et al. Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation , 2006, Clinical Cancer Research.
[34] G. Scagliotti,et al. Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[35] J. Minna,et al. Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features , 2006, Clinical Cancer Research.
[36] L. Sobin,et al. World Health Organization classification of tumors , 2000, Cancer.
[37] Sun-Mi Park,et al. CD95 promotes tumour growth , 2011, Nature.
[38] E. Vokes,et al. Lung cancer , 2000, The Lancet.
[39] A. Regev,et al. SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.
[40] James Ireland,et al. Analysis of molecular inversion probe performance for allele copy number determination , 2007, Genome Biology.
[41] Xuetao Cao,et al. Fas Signal Promotes Lung Cancer Growth by Recruiting Myeloid-Derived Suppressor Cells via Cancer Cell-Derived PGE21 , 2009, The Journal of Immunology.
[42] K. Palm,et al. Neuralized-2: expression in human and rodents and interaction with Delta-like ligands. , 2009, Biochemical and biophysical research communications.
[43] Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3 , 2010 .
[44] S. Koo,et al. Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung. , 2008, Cancer genetics and cytogenetics.
[45] Hanlee P. Ji,et al. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia. , 2009, Cancer genetics and cytogenetics.
[46] C. McCulloch,et al. Multiple roles of α-smooth muscle actin in mechanotransduction , 2006 .
[47] Cheol‐Hee Kim,et al. Neuralized-2 Regulates a Notch Ligand in Cooperation with Mind Bomb-1* , 2006, Journal of Biological Chemistry.
[48] Dima Suki,et al. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases , 2009, Cancer.
[49] I. Sancho-Martinez,et al. Yes and PI3K bind CD95 to signal invasion of glioblastoma. , 2008, Cancer cell.
[50] L. Rubinstein,et al. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] M. Maitland,et al. Personalized treatment of lung cancer. , 2011, Seminars in oncology.
[52] M. Kris,et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] D. Ettinger,et al. Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.
[54] Stage Iiia. Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small-Cell Lung Cancer Guideline , 2007 .
[55] G. Owens,et al. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. , 1986, The Journal of biological chemistry.
[56] C. Moran,et al. Importance of molecular features of non-small cell lung cancer for choice of treatment. , 2011, The American journal of pathology.
[57] René Bernards,et al. A progression puzzle. , 2002, Nature.
[58] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[59] G. Pelosi,et al. Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.
[60] B. Molnár,et al. Increase of α-SMA+ and CK+ Cells as an Early Sign of Epithelial-Mesenchymal Transition during Colorectal Carcinogenesis , 2012, Pathology & Oncology Research.
[61] M. Peter,et al. The CD95 Receptor: Apoptosis Revisited , 2007, Cell.
[62] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[63] T. J. Robnett,et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.